Have you ever heard of a guy named Clay Siegall? More than likely you probably haven’t, but Clay Siegall is playing a crucial role in the fight against cancer. This disease is pretty wide spread all over the globe no mater the location and it’s wrath can affect the strongest of individuals. Fortunately the fight against cancer has stepped it’s game up (via) Antibody Based Therapies. These advanced therapies are known as (ADC) or Antibody Drug Conjugates and they are much more affective than previous cancer therapies of the past. All of this ties together in some form or another and this is how.
Dr. Clay Siegall is the CEO and President for one of the leading biotech organizations in the world that specialize in defeating cancer. Seattle Genetics produces many of the most advanced antibody breakthrough therapies in the world and from it’s effort, many lives have been saved. The advanced antibody drug conjugates actually deliver a cell killing blow straight into dangerous cancer cells within the body. When this happens, other good cells within the body remain untouched. This action drastically cuts down on ill side effects that can make a person feel as ill as the cancer itself. Dr. Siegall has produced a winning strategy that is now being used worldwide in over 60 countries. This guy just know how to get things done in an efficient and effective way. Forbes ranked the organization as one of the fastest growing companies in the country with sales of over $325 Million to date.
Thanks to Dr. Siegall’s extensive knowledge and expertise, the company’s flagship drug ADCETRIS has been entered into multiple strategic license deals. You won’t find to many other individuals has done what Dr. Siegall has. The guy literally puts his life on hold to help save others. The future is looking much more promising in the fight against cancer and Dr. Siegall’s winning strategy is paying huge dividends.